Press Releases
Filters
November 8, 2021
Viatris Reports Strong Third Quarter Results, Raises 2021 Financial Guidance and Announces Virtual Investor Event on January 7, 2022
October 20, 2021
Viatris' First-Ever Interchangeable Insulin Biosimilar Preferred on Express Scripts' Largest Formulary
October 13, 2021
Viatris Inc. to Release Third Quarter 2021 Financial Results on Nov. 8, 2021
July 28, 2021
Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes
July 8, 2021
Viatris Inc. to Release Second Quarter 2021 Financial Results on Aug. 9, 2021
Displaying 111 - 120 of 139